Division of Hematology News

Blocking disease-causing biological signals may lead to a new treatment for the life-threatening childhood blood disorder Fanconi anemia.

CHOP breakthrough helps scientists edge closer to defeating a longtime enemy of human health: hemophilia, the inability to form blood clots.

Researchers have found a key protein that could become a target for a new treatment for sickle cell disease. In lab tests, blocking the protein reduces sickling that distorts red blood cells.

A team of gene therapy researchers has reported on a highly active gene variant that achieved sustained factor levels in 10 adults, with no adverse effects.

In the pediatric population, toddlers and adolescent girls are most commonly affected by iron deficiency anemia (IDA). This case study explores when IDA should prompt investigation for malabsorption or bleeding.

Read about the prevalence of inherited thrombophilias (IT), potential benefits and limitations of IT testing in healthy children, and recommendations from Children Hospital's experts.

Hematology fellow Jessica Foster, MD, reflects on the often difficult assessment of neurological symptoms in the sickle cell patient population.

Examine the case of a 20-month-old patient diagnosed with immune thrombocytopenia after presenting with a red, pinpoint rash and a recent history of bruising.